Instrument Inactif

Communiqués Scibase AB Swiss Exchange

Actions

Cours en clôture Swiss Exchange Autres places de cotation
- ^SEK	-

10/05	SciBase recevra 9 millions de couronnes suédoises de produits initiaux de l'émission de droits	MT
05/04	SciBase prévoit une levée de fonds de 48 millions de couronnes suédoises pour la commercialisation et la croissance aux États-Unis	MT

SciBase welcomes new chairman and thanks the former	13/06	AQ
Annual general meeting has been held in SciBase Holding AB (publ)	13/06	AQ
SciBase strengthens the US organization with experienced leader in dermatology	13/06	AQ
Scibase - Stepping up the pace	03/06	AQ
Scibase : Interim report Q1 2024 Press Release	31/05	PU
Interim report	31/05	AQ
Today is the first day of trading in the new shares and warrants of series TO 2 issued in connection with the completed capital raising	31/05	AQ
SciBase receives first order in Austria	30/05	AQ
SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing	29/05	AQ
New German study shows Nevisense significantly improves dermatologists clinical decisions	22/05	AQ
Scibase : Annual Report 2023 Report	22/05	PU
SciBase publishes the Annual report for 2023	22/05	AQ
SciBase announces outcome in the directed issue of units	13/05	AQ
Scibase : Appendix EGM 2024	13/05	PU
Scibase : Presentation Board of directors AGM 2024	13/05	PU
Scibase : Postal voting form AGM 2024	13/05	PU
Scibase : Power of attorney form AGM 2024	13/05	PU
Notice to attend the annual general meeting in SciBase Holding AB (publ)	13/05	AQ
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)	13/05	AQ
SciBase announces outcome in rights issue of units	10/05	AQ

Aucun résultat pour cette recherche